David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Poiesis and Praxis 2 (4):315-328 (2004)
The new generation of psychopharmacological products have proved their efficacy. Some neuro-degenerative diseases, such as Parkinson's and Alzheimer's diseases, could be treated by means of the gene therapy. Although the aetiology of such diseases is still not completely known, it has been proven that the patients lack some substances that could be produced by means of the transfer of in vivo or ex vivo genes that codify them in the proper places of the brain. Furthermore, it is announced that the implantation in laboratory grown stem cells of diverse origins is very hopeful. Cerebral (micro)electronic implants could be effective to fight some motor diseases as well as sensory functions. All of these kinds of new treatments need to be tested through clinical research. Most national legislation includes provisions on the clinical trials of drugs and a series of guarantees, procedures and conditions which are designed to ensure protection for individuals used in experiments and to assure that the trial is indeed of scientific relevance. However, few lay down similar regulations or provide for specific controls for the research of other treatments. Finally, enhancement of psychic capacities pose new problems for society as well as do the need for new legal decisions
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Rieke van der Graaf & Johannes J. M. van Delden (2012). On Using People Merely as a Means in Clinical Research. Bioethics 26 (2):76-83.
Joanna Różyńska & Marek Czarkowski (2007). Emergency Research Without Consent Under Polish Law. Science and Engineering Ethics 13 (3):337-350.
Riekeder Graaf & Johannes J. M. Delden (forthcoming). On Using People Merely as a Means in Clinical Research. Bioethics.
Adrian Carter, Emily Bell, Eric Racine & Wayne Hall (2011). Ethical Issues Raised by Proposals to Treat Addiction Using Deep Brain Stimulation. Neuroethics 4 (2):129-142.
Marek Labon (2006). Conducting Clinical Research in Polish Conditions. Science and Engineering Ethics 12 (1):185-188.
John D. Loike Moshe Tendler (2008). Reconstituting a Human Brain in Animals: A Jewish Perspective on Human Sanctity. Kennedy Institute of Ethics Journal 18 (4):pp. 347-367.
Shawn Fabrice Jotterand, Archie M. McClintock, Mustafa A. Alexander & M. Husain (2010). Ethics and Informed Consent of Vagus Nerve Stimulation (Vns) for Patients with Treatment-Resistant Depression (Trd). Neuroethics 3 (1).
Cynthia B. Cohen Peter J. Cohen (2010). International Stem Cell Tourism and the Need for Effective Regulation: Part II: Developing Sound Oversight Measures and Effective Patient Support. Kennedy Institute of Ethics Journal 20 (3):207-230.
Lizabeth A. Barclay & Karen S. Markel (2009). Ethical Fairness and Human Rights: The Treatment of Employees with Psychiatric Disabilities. [REVIEW] Journal of Business Ethics 85 (3):333 - 345.
Added to index2009-01-28
Total downloads3 ( #483,044 of 1,726,249 )
Recent downloads (6 months)1 ( #369,877 of 1,726,249 )
How can I increase my downloads?